Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH)

Suissa, 1994, A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists, Am J Respir Crit Care Med, 149, 604, 10.1164/ajrccm.149.3.8118625 Psaty, 1995, The risk of myocardial infarction associated with antihypertensive drug therapies, JAMA, 274, 620, 10.1001/jama.274.8.620 Spitzer, 1996, Third generation oral contraceptives and risk of venous thromboembolic disorders, Transnational Research Group on Oral Contraceptives and the Health of Young Women, BMJ, 312, 83 Rosenberg, 1998, Calcium channel blockers and the risk of cancer, JAMA, 279, 1000, 10.1001/jama.279.13.1000 Grobbee, 1997, Confounding and indication for treatment in evaluation of drug treatment for hypertension, BMJ, 315, 1151, 10.1136/bmj.315.7116.1151 Petri, 1991, Channeling bias in the interpretation of drug effects, Stat Med, 10, 577, 10.1002/sim.4780100409 Bloemenkamp, 1999, Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias, Arch Intern Med, 159, 65, 10.1001/archinte.159.1.65 Farmer, 1996, Oral contraceptive switching patterns in the United Kingdom, Eur J Contracept Reprod Health Care, 1, 31, 10.3109/13625189609150653 Garbe, 1998, Selection of controls in database case-control studies, J Clin Epidemiol, 51, 129, 10.1016/S0895-4356(97)00263-1 Berry, 1984, The development of human benign prostatic hyperplasia with age, J Urol, 132, 474, 10.1016/S0022-5347(17)49698-4 Abrams, 1995, Tamsulosin, a selective alpha 1c-adrenoceptor antagonist, The European Tamsulosin Study Group. Br J Urol, 76, 325 Holtgrewe, 1998, Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia, Urology, 51, 1, 10.1016/S0090-4295(98)00048-X Chapple, 1998, Pharmacotherapy for benign prostatic hyperplasia—the potential for alpha 1-adrenoceptor subtype-specific blockade, Br J Urol, 81, 34, 10.1046/j.1464-410X.1998.0810s1034.x Narayan, 1998, Overview of alpha-blocker therapy for benign prostatic hyperplasia, Urology, 51, 38, 10.1016/S0090-4295(98)00054-5 Roehrborn, 1998, Meta-analysis of randomized clinical trials of finasteride, Urology, 51, 46, 10.1016/S0090-4295(98)00055-7 1998, Drug treatment of hypertension in the elderly, Br J Urol, 81, 21 Chapple, 1996, Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia, Eur Urol, 29, 129, 10.1016/S1569-9056(04)90505-2 Pool, 1996, Doxazosin, Br J Clin Pract, 50, 154 Boyle, 1995, The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension, Scand J Urol Nephrol Suppl, 168, 7 Ottervanger, 1997, Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature, Eur J Clin Pharmacol, 53, 105, 10.1007/s002280050346 Herings, 1995, Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme, Lancet, 345, 1195, 10.1016/S0140-6736(95)91988-0 Herings, 1995, Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life, Arch Intern Med, 155, 1801, 10.1001/archinte.155.16.1801 Leufkens, 1994, Automated record linkage and other approaches to pharmacoepidemiology in The Netherlands, 231 Von Korff, 1992, A chronic disease score from automated pharmacy data, J Clin Epidemiol, 45, 197, 10.1016/0895-4356(92)90016-G Merlo, 1996, Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs, BMJ, 313, 457, 10.1136/bmj.313.7055.457 Stoevelaar, 1999, Treatment choice for benign prostatic hyperplasia, J Urol, 161, 133, 10.1016/S0022-5347(01)62083-4 Wolfs, 1994, Prevalence and detection of micturition problems among 2,734 elderly men, J Urol, 152, 1467, 10.1016/S0022-5347(17)32447-3 Wille-Gussenhoven, 1997, Prostate symptoms in general practice, Scand J Prim Health Care, 15, 39, 10.3109/02813439709043428 Bosch, 1995, Natural history of benign prostatic hyperplasia, Urology, 46, 34, 10.1016/S0090-4295(99)80248-9 Lukacs, 1996, Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners, Urology, 48, 731, 10.1016/S0090-4295(96)00302-0 Michel, 1998, Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms, J Urol, 160, 784, 10.1016/S0022-5347(01)62787-3